EQS — Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2026: Earnings below prior year — net sales up — forecast confirmed

EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Results / Quarter/Forecast / Other Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2026: Earnings below prior year — net sales up — forecast confirmed 14-Oct-2026 / 19:32 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by 1 EQS News — a service of 2 EQS Group.

The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. 7 million).

1 million. 8 percent). The lower net sales growth in the third quarter of 2026 was offset by a disproportionate increase in functional expenses. At the same time, the comparison base was high: In the third quarter of 2025, EBIT more than doubled due to significant net sales growth driven by catch-up effects and moderate cost development.

3 million). 0 million). 3 million). 6 percent).

The main reason for this was the customs duty refunds. 1 million). 4 million). This development was due in particular to high demand in the regions Germany, Americas, and Asia-Pacific.

7 million). 1 million). 6 million). 5 million).

The main reason for this was the major order from Mexico for hospital infrastructure systems in the second quarter of 2025. Adjusted for this effect, order intake in medical would have increased slightly (net of currency effects) in the first nine months of 2026. 5 million). 3 million).

1 percent). 1 million). 3 percent). 9 million from refunded customs duties.

1 million to the third quarter. 8 million in total — relates to customs payments from the current fiscal year and is therefore recognized with no impact on earnings. 0 percent. The quarterly statement will be published on October 29, 2026.

Drägerwerk AG & Co. KGaA Moislinger Allee 53—55 23558 Lübeck, Germany Investor Relations: Thomas Fischler Tel. com Corporate Communications: Ulrike Abratis Tel. com Disclaimer This ad hoc report contains statements on the future development of Dräger Group.

These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors.

They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at for information on alternative performance measures used.

End of Inside Information ══════════════════════════════════════════════════════════════════════════ 14-Oct-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: 3 EQS News ══════════════════════════════════════════════════════════════════════════ Language: English Company: Drägerwerk AG & Co.

com Internet: ISIN: DE0005550602, DE0005550636 (Vorzugsaktien) WKN: 555060, 555063 (Vorzugsaktien) Indices: SDAX, TecDax Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; London, Aquis, Stockholm, BX, SIX, Vienna Stock Exchange LEI Code: 5493005UFVHY0PPNKD75 EQS News ID: 2416044 End of Announcement EQS News Service 2416044 14-Oct-2026 CET/CEST References Visible links 1. 2. 3.